Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury.
Fixing the jugular flow reduces ventricle volume and improves brain perfusion.
Pharmaceutical Approval Update.
Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.
Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Role of chondroitin sulfate (CS) modification in the regulation of protein tyrosine receptor type Z (PTPRZ) activity: pleiotrophin-PTPRZ-A signaling is involved in oligodendrocyte differentiation.
A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia.
Intravenous Methylprednisolone-Induced Nocturnal Sinus Bradycardia in a Multiple Sclerosis Patient.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions.
The environmental risk factors in multiple sclerosis susceptibility: A case-control study.
Effects of Hindlimb Unweighting on MBP and GDNF Expression and Morphology in Rat Dorsal Root Ganglia Neurons.
Key Points for Issue.
Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.
Ghrelin: A link between ageing, metabolism and neurodegenerative disorders.
Pages
« first
‹ previous
…
788
789
790
791
792
793
794
795
796
…
next ›
last »